Kinetic modeling of [99mTc]TRODAT- 1: A dopamine transporter imaging agent

Journal of Nuclear Medicine

Volumn 40, Issue 1, 1999, Pages 150-158

  Kushner, Steven A ^a   McElgin, William T ^a   Kung, Mei Ping ^a   Mozley, P David ^a   Plössl, Karl ^a   Meegalla, Sanath K ^a   Mu, Mu ^a   Dresel, Stefan ^a   Vessotskie, Janet M ^a   Lexow, Nedra ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dopamine neuron; Parkinson's disease; SPECT; Striatum

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; CARRIER PROTEIN; DIAGNOSTIC AGENT; DOPAMINE; DOPAMINE TRANSPORTER; MEMBRANE PROTEIN; NERVE PROTEIN; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRODAT 1; TECHNETIUM TC 99M TRODAT-1; TROPANE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BABOON; BRAIN BLOOD FLOW; BRAIN MAPPING; DIAGNOSTIC IMAGING; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; BRAIN; FEMALE; HUMAN; METABOLISM; PAPIO; SCINTISCANNING;

ANIMALS; BRAIN; CARRIER PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; ORGANOTECHNETIUM COMPOUNDS; PAPIO; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0032587238     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Iversen LL. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol. 1971;41:571-591.
2. Reith MEA, ed. Neurotransmitter Transporters: Structure, Function, and Regulation. Totowa, NJ: Humana Press: 1997:405.
3. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996;379:606-612.
4. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Ann Rev Neurosci. 1993;16:73-93.
5. Fowler JS, Volkow ND, MacGregor RR, et al. Comparative PET studies of the kinetics and distribution of cocaine and cocaethylene in baboon brain. Synapse. 1992;12:220-227.
6. 11C]-W1N35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol. 1993;34:423-431.
7. 11C]W1N35,428. Synapse 1993;15:130-142.
8. 11C]d-threo and L-threo-methylphenidate in the human and baboon brain. Psychopharmacology 1997;131:71-78.
9. Innis RB. Single photon emission tomography imaging of dopamine terminal innervation: a potential clinical tool in Parkinson's disease [editorial; review]. Eur J Nucl Med. 1994;21:1-5.
10. Seibyl JP, Laruelle MA, Van Dyck CH, et al. Reproducibility of iodine-123-β-CIT SPECT brain measurement of dopamine transporters. J Nucl Med. 1996;37:222-228.
11. Mozley PD, Stubbs JB, Kim H-J, et al. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters. J Nucl Med. 1996;37:151-159.
12. 123I]IPTand single-photon emission tomography. Eur J Nucl Med. 1997;24:415-421.
13. Abi-Dargham A, Gandelman MS, DeErausquin GA, et al. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of β-CIT. J Nucl Med. 1996;37:1129-1133.
14. Neumeyer JL, Tamagnan G, Wang S, et al. N-substituted analogs of 2 beta-carbomethoxy-3 beta-(4′-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J Med Chem. 1996;39:543-548.
15. Fischman AJ, Babich JW, Elmaleh DR, et al. SPECT imaging of dopamine transporter sites in normal and MPTP-treated rhesus monkeys. J Nucl Med. 1997;38:144-150.
16. Innis RB, Seibyl JP, Scanley BE, et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Natl Acad Sci U S A. 1993;90:11965-11969.
17. Jurisson SS, Berning D, Jia W, Ma D-S. Coordination compounds in nuclear medicine. Chem Rev. 1993;93:1137-1156.
18. Horn RK, Katzenellenbogen JA. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results. Nucl Med Biol. 1997;24:485-498.
19. Tamagnan G, Gao YG, Baldwin RM, Zoghbi SS, Neumeyer JL. Synthesis of beta-CIT-BAT, a potential Tc-99m imaging ligand for dopamine transporter. Tetrahedron Lett. 1996;37:4353-4356.
20. Meltzer PC, Blundell P, Jones AG, et al. A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain. J Med Chem. 1997;40: 1835-1844.
21. Meegalla SK, Plössl K, Kung M-P, et al. Synthesis and characterization of Tc-99m labeled tropanes as dopamine transporter imaging agents. J Med Chem. 1997;40: 9-17.
22. 99mTc]TRODAT-1 as dopamine transporter imaging agents. J Med Chem. 1998;41:428-136.
23. Kung HF, Kim H-J, Kung M-P, Meegalla SK, Plössl K, Lee H-K. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med. 1996;23:1527-1530.
24. 99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine Iransponer imaging agent. Eur J Nucl Med. 1997;24:372-380.
25. 123I]beta-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab. 1994;14:982-994.
26. Wong DF, Gjedde A. Compartments and reaction volumes of brain fluid spaces: shaken, not stirred. J Nucl Med. 1996;37:126-127.
27. Delforge J, Syrota A, Bendriem B. Concept of reaction volume in the in vivo ligand-receptor model. J Nucl Med. 1996;37:118-125.
28. Kushner SA, McElgin WT, Mozley PD, Kung HF. A fully-automated method of multi-modal coregislration using external fiducial markers [Abstract]. J Nucl Med. 1996;37:990P.
29. Mintun MA, Raichle ME, Kilboum MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 1984;15:217-227.
30. Abi-Dargham A, Laruelle M, Seibyl J, et al. SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. J Nucl Med. 1994;35:228-238.
31. Larvelle M, Abi-Dargham A, Al-Tikriti MS, et al. SPECT quantification of [I-123]iomazenil binding to benzodiazepine receptors in nonhuman primates. 2. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters. J Cereb Blood Flow Metab. 1994;14:453-465.
32. Phelps ME, Huang SC, Hoffman EJ, Selin C, Solokoff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6:371-382.
33. Levenberg K. A method for the solution of certain problems in least squares. Quant Appl Math. 1944;2:164-168.
34. 99mTc]TRODAT-1: a new dopamine transporter imaging agent [Abstract IV-23]. Proc XIIth Int Symp Radiopharm Chem. Uppsala, Sweden. 1997;40:263-265.
35. Carson RE. The developmenl and application of mathematical models in nuclear medicine. J Nucl Med. 1991;32:2206-2208.
36. 11C]carfentanil binding to opiate receptors in humans measured by positron emission tomography. J Cereb Blood Flow Metab 1989;9:398-409.
37. Abi-Dargham A, Gandelman M, Zoghbi SS, et al. Reproducibilily of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. J Nucl Med. 1995;36:167-175.
38. 3H]2β-carbomethoxy-3β-(4-fluorophenyl)Tropane. Mol Phamacol. 1989;36:518-524.
39. 125I]iodophenyl) tropane-2beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions. J Neurochem. 1994;62:978-986.